
PP-7-5 phase II study of paclitaxel (P) and eplrubicin (E) as first-line therapy in patients (PTS) with metastatic breast cancer (MBC)
Ch. Thomssen, H.-J. Lück, A. du Bois, B. Lisboa, M. Untch, G. Köhler, D. Hecker, K. DiergartenVolume:
32
Année:
1996
Langue:
english
DOI:
10.1016/0959-8049(96)84223-7
Fichier:
PDF, 175 KB
english, 1996